CXCL1 and its receptor, CXCR2, mediate murine sickle cell vaso-occlusion during hemolytic transfusion reactions

Journal of Clinical Investigation

Volumn 121, Issue 4, 2011, Pages 1397-1401

  Jang, Jung Eun ^a   Hod, Eldad A ^b   Spitalnik, Steven L ^b   Frenette, Paul S ^a,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TRANSFUSION REACTION; BLOOD VESSEL OCCLUSION; ERYTHROCYTE; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SICKLE CELL ANEMIA; VENULE;

ANEMIA, SICKLE CELL; ANIMALS; BLOOD TRANSFUSION; CHEMOKINE CXCL1; DISEASE MODELS, ANIMAL; HEMOLYSIS; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHENYLUREA COMPOUNDS; RECEPTORS, INTERLEUKIN-8B; RECOMBINANT PROTEINS; VASCULAR DISEASES; VENULES;

EID: 79953300709     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI45336     Document Type: Article

References (23)

1. Steinberg MH. Management of sickle cell disease. N Engl J Med. 1999;340(13):1021-1030. (Pubitemid 29157635)
2. Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest. 2007;117(4):850-858. (Pubitemid 46556737)
3. Morris CR. Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology Am Soc Hematol Educ Program. 2008:177-185.
4. Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood. 1993;81(5):1109-1123. (Pubitemid 23067344)
5. Cox JV, Steane E, Cunningham G, Frenkel EP. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med. 1988;148(11):2485-2489.
6. Vichinsky EP. Current issues with blood transfusions in sickle cell disease. Semin Hematol. 2001; 38(1 suppl 1):14-22. (Pubitemid 32110268)
7. Diamond WJ, Brown FL Jr, Bitterman P, Klein HG, Davey RJ, Winslow RM. Delayed hemolytic transfusion reaction presenting as sickle-cell crisis. Ann Intern Med. 1980;93(2):231-234.
8. Davenport RD. Pathophysiology of hemolytic transfusion reactions. Semin Hematol. 2005;42(3):165-168. (Pubitemid 41019445)
9. Schirmer DA, et al. Mouse models of IgG- and IgMmediated hemolysis. Blood. 2007;109(7):3099-3107. (Pubitemid 46482113)
10. Hod EA, et al. Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions. Blood. 2008;112(3):891-894.
11. Meyer D, et al. FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia. Blood. 1998;92(11):3997-4002. (Pubitemid 28544311)
12. Davenport RD, Burdick M, Moore SA, Kunkel SL. Cytokine production in IgG-mediated red cell incompatibility. Transfusion. 1993;33(1):19-24. (Pubitemid 23040324)
13. Rakic S. [New findings on the physiopathology of acute hemolytic transfusion reactions]. Med Pregl. 1999;52(1-2):19-24.
14. Goncalves MS, et al. Interleukin 8 as a vaso-occlusive marker in Brazilian patients with sickle cell disease. Braz J Med Biol Res. 2001;34(10):1309-1313. (Pubitemid 33014499)
15. Turhan A, Weiss LA, Mohandas N, Coller BS, Frenette PS. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci U S A. 2002;99(5):3047-3051. (Pubitemid 34240583)
16. Chang J, Shi PA, Chiang EY, Frenette PS. Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion. Blood. 2008;111(2):915-923.
17. Kaul DK, Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest. 2000; 106(3):411-420. (Pubitemid 30655641)
18. Kalambur VS, et al. Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy. Am J Hematol. 2004;77(2):117-125. (Pubitemid 39281854)
19. Belcher JD, et al. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. Am J Physiol Heart Circ Physiol. 2005;288(6):H2715-H2725. (Pubitemid 40720650)
20. Paszty C, et al. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science. 1997;278(5339):876-878. (Pubitemid 27467927)
21. Hidalgo A, Chang J, Jang JE, Peired AJ, Chiang EY, Frenette PS. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med. 2009; 15(4):384-391.
22. Belperio JA, et al. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator- induced lung injury. J Clin Invest. 2002; 110(11):1703-1716. (Pubitemid 35424249)
23. Chintakuntlawar AV, Chodosh J. Chemokine CXCL1/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis. J Interferon Cytokine Res. 2009;29(10):657-666.